If you are looking for support from the community around you, a discussion with others about living with metastatic triple-negative breast cancer, or an opportunity to be an advocate for those who need a guiding hand, there are active groups available for you to explore. Connect with an organization that fits you and your lifestyle.
Jump to:
Providing reliable, easy-to-understand, and actionable information and support resources to help you make the best decisions for your lives.
Ensuring that all people impacted by cancer are empowered by knowledge, strengthened by action, and sustained by community.
Offering on-demand emotional, practical, and evidence-based content that is meaningful to those newly diagnosed, in treatment, posttreatment, and living with metastatic disease.
Working to transform the lives of people with metastatic breast cancer as the national leader in collaborative action, made up of nonprofit cancer organizations from pharmaceutical and biotech industry members to individual patient advocates.
Sustaining hope for those living with stage 4 metastatic breast cancer (mBC) as a volunteer-led, nonprofit organization, funding vital research to help improve the longevity and quality of life for mBC patients.
Supporting, educating, and empowering anyone who has been diagnosed with breast or gynecologic cancers, providing outreach to the general public about signs and symptoms. We are a community of survivors, those living with cancer, and healthcare professionals.
A credible source for triple negative breast cancer information, a catalyst for science and patient advocacy, and a caring community with meaningful services for patients and their families.
Working to create a more equitable and accessible health care system for the Latiné community around issues of cancer.
Working to improve the lives of LGBT cancer survivors and those at risk by educating the LGBT community about risks and screening, and advocating for LGBT survivors in mainstream cancer organizations, the media, and research.
Improving the lives of Jewish women and families living with or at increased genetic risk for breast or ovarian cancer through personalized support, and saving lives through educational outreach as a national nonprofit organization.
Educating and empowering women before, during, and after breast cancer through unique programs for all backgrounds, including those at heightened risk, and those with less access to care.
Providing breast cancer coaching and navigation support in order to disrupt outcome disparities so every patient receives the care they deserve.
Driving the collaborative efforts of patients, survivors, advocates, advocacy organizations, health care professionals, researchers, and pharmaceutical companies to work towards the common goal of eradicating Black Breast Cancer.
Strengthening the community, addressing the unique needs, amplifying the voice, and improving the quality of life of young adults affected by breast cancer locally, nationally, and internationally.
These resources are not controlled or owned by Gilead, and Gilead is not responsible for their content.
TRODELVY® (sacituzumab govitecan-hziy) is a prescription medicine used to treat adults with triple-negative breast cancer (negative for estrogen and progesterone hormone receptors and HER2) that has spread to other parts of the body (metastatic) or cannot be removed by surgery, and who have received two or more prior treatments, including at least one treatment for metastatic disease.
It is not known if TRODELVY is safe and effective in people with moderate or severe liver problems or in children.
Do not receive TRODELVY if you have had a severe allergic reaction to TRODELVY. Ask your healthcare provider if you are not sure.
Allergic and infusion-related reactions which can be serious and life-threatening. Tell your healthcare provider or nurse right away if you get any of the following symptoms during your infusion of TRODELVY or within 24 hours after: swelling of your face, lips, tongue, or throat; hives; skin rash, itching, or flushing of your skin; fever; difficulty breathing or wheezing; lightheadedness, dizziness, feeling faint, or pass out; or chills or shaking chills (rigors).
Nausea and vomiting are common with TRODELVY and can sometimes be severe. Before each dose of TRODELVY, you will receive medicines to help prevent nausea and vomiting along with medicines to take home with instructions about how to take them. Call your healthcare provider right away if you have nausea or vomiting that is not controlled with the medicines prescribed for you. Your healthcare provider may decide to decrease your dose or stop TRODELVY if your nausea and vomiting is severe and cannot be controlled with anti-nausea medicines.
Before receiving TRODELVY, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Certain medicines may affect the way TRODELVY works.
The most common side effects of TRODELVY include decreased white blood cell (leukocyte and lymphocyte) and red blood cell counts, feeling tired or weak, hair loss, constipation, increased sugar levels in the blood, decreased protein levels (albumin) in the blood, decreased appetite, changes in kidney function test, increased levels of enzyme called alkaline phosphatase in the blood (test for liver or bone problems), and decreased levels of magnesium, potassium, and sodium in the blood.
These are not all of the possible side effects of TRODELVY. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please click to see Important Facts about TRODELVY, including Important Warning.